Your browser doesn't support javascript.
loading
Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.
Gray, Ronan T; Loughrey, Maurice B; Bankhead, Peter; Cardwell, Chris R; McQuaid, Stephen; O'Neill, Roisin F; Arthur, Kenneth; Bingham, Victoria; McGready, Claire; Gavin, Anna T; James, Jacqueline A; Hamilton, Peter W; Salto-Tellez, Manuel; Murray, Liam J; Coleman, Helen G.
Affiliation
  • Gray RT; Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Loughrey MB; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Bankhead P; Department of Tissue Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
  • Cardwell CR; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • McQuaid S; Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • O'Neill RF; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Arthur K; Northern Ireland Biobank, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Bingham V; Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • McGready C; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Gavin AT; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • James JA; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Hamilton PW; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Salto-Tellez M; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Murray LJ; Department of Tissue Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
  • Coleman HG; Northern Ireland Biobank, Queen's University Belfast, Belfast, Northern Ireland, UK.
Br J Cancer ; 116(12): 1652-1659, 2017 Jun 06.
Article in En | MEDLINE | ID: mdl-28524155

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Proto-Oncogene Proteins p21(ras) / Colonic Neoplasms / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hydroxymethylglutaryl CoA Reductases Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2017 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Proto-Oncogene Proteins p21(ras) / Colonic Neoplasms / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hydroxymethylglutaryl CoA Reductases Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2017 Type: Article Affiliation country: United kingdom